JPWO2022093310A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022093310A5 JPWO2022093310A5 JP2023525078A JP2023525078A JPWO2022093310A5 JP WO2022093310 A5 JPWO2022093310 A5 JP WO2022093310A5 JP 2023525078 A JP2023525078 A JP 2023525078A JP 2023525078 A JP2023525078 A JP 2023525078A JP WO2022093310 A5 JPWO2022093310 A5 JP WO2022093310A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- amino acid
- domain
- seq
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108020001507 fusion proteins Proteins 0.000 claims description 97
- 102000037865 fusion proteins Human genes 0.000 claims description 97
- 150000001413 amino acids Chemical group 0.000 claims description 81
- 210000004475 gamma-delta t lymphocyte Anatomy 0.000 claims description 63
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims description 61
- 235000018102 proteins Nutrition 0.000 claims description 55
- 102000004169 proteins and genes Human genes 0.000 claims description 55
- 108090000623 proteins and genes Proteins 0.000 claims description 55
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 48
- 206010028980 Neoplasm Diseases 0.000 claims description 40
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 38
- 229920001184 polypeptide Polymers 0.000 claims description 35
- 201000011510 cancer Diseases 0.000 claims description 34
- 230000008685 targeting Effects 0.000 claims description 33
- 235000001014 amino acid Nutrition 0.000 claims description 27
- -1 spacer amino acid Chemical class 0.000 claims description 27
- 125000000539 amino acid group Chemical group 0.000 claims description 26
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 24
- 101000984934 Homo sapiens Butyrophilin subfamily 3 member A1 Proteins 0.000 claims description 24
- 239000008194 pharmaceutical composition Substances 0.000 claims description 24
- 102100027138 Butyrophilin subfamily 3 member A1 Human genes 0.000 claims description 23
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 20
- 239000012634 fragment Substances 0.000 claims description 20
- 210000004027 cell Anatomy 0.000 claims description 17
- 210000004881 tumor cell Anatomy 0.000 claims description 17
- 108010017533 Butyrophilins Proteins 0.000 claims description 16
- 102000004555 Butyrophilins Human genes 0.000 claims description 16
- 101000984926 Homo sapiens Butyrophilin subfamily 2 member A1 Proteins 0.000 claims description 14
- 102100027157 Butyrophilin subfamily 2 member A1 Human genes 0.000 claims description 13
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 12
- 239000004471 Glycine Substances 0.000 claims description 12
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 12
- 239000013604 expression vector Substances 0.000 claims description 12
- 230000003213 activating effect Effects 0.000 claims description 10
- 239000000427 antigen Substances 0.000 claims description 10
- 108091007433 antigens Proteins 0.000 claims description 10
- 102000036639 antigens Human genes 0.000 claims description 10
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims description 9
- 102100025430 Butyrophilin-like protein 3 Human genes 0.000 claims description 9
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims description 9
- 101000934741 Homo sapiens Butyrophilin-like protein 3 Proteins 0.000 claims description 9
- 101000934742 Homo sapiens Butyrophilin-like protein 8 Proteins 0.000 claims description 9
- 230000035755 proliferation Effects 0.000 claims description 9
- 102100025371 Butyrophilin-like protein 8 Human genes 0.000 claims description 8
- 101000984917 Homo sapiens Butyrophilin subfamily 3 member A2 Proteins 0.000 claims description 8
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 8
- 102100027155 Butyrophilin subfamily 3 member A2 Human genes 0.000 claims description 7
- 102100026094 C-type lectin domain family 12 member A Human genes 0.000 claims description 7
- 230000004913 activation Effects 0.000 claims description 7
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims description 6
- 239000004475 Arginine Substances 0.000 claims description 6
- 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 claims description 6
- 208000003174 Brain Neoplasms Diseases 0.000 claims description 6
- 102100027154 Butyrophilin subfamily 3 member A3 Human genes 0.000 claims description 6
- 206010014759 Endometrial neoplasm Diseases 0.000 claims description 6
- 101000984916 Homo sapiens Butyrophilin subfamily 3 member A3 Proteins 0.000 claims description 6
- 208000008839 Kidney Neoplasms Diseases 0.000 claims description 6
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 6
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 6
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 6
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 6
- 206010025323 Lymphomas Diseases 0.000 claims description 6
- 239000004472 Lysine Substances 0.000 claims description 6
- 208000025205 Mantle-Cell Lymphoma Diseases 0.000 claims description 6
- 102100024964 Neural cell adhesion molecule L1 Human genes 0.000 claims description 6
- 102100040678 Programmed cell death protein 1 Human genes 0.000 claims description 6
- 206010060862 Prostate cancer Diseases 0.000 claims description 6
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 6
- 206010038389 Renal cancer Diseases 0.000 claims description 6
- 206010039491 Sarcoma Diseases 0.000 claims description 6
- 208000005718 Stomach Neoplasms Diseases 0.000 claims description 6
- 208000033559 Waldenström macroglobulinemia Diseases 0.000 claims description 6
- 230000000735 allogeneic effect Effects 0.000 claims description 6
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 6
- 230000001684 chronic effect Effects 0.000 claims description 6
- 230000003325 follicular Effects 0.000 claims description 6
- 201000003444 follicular lymphoma Diseases 0.000 claims description 6
- 206010017758 gastric cancer Diseases 0.000 claims description 6
- 239000004220 glutamic acid Substances 0.000 claims description 6
- 201000009277 hairy cell leukemia Diseases 0.000 claims description 6
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 6
- 201000010982 kidney cancer Diseases 0.000 claims description 6
- 208000032839 leukemia Diseases 0.000 claims description 6
- 201000007270 liver cancer Diseases 0.000 claims description 6
- 208000014018 liver neoplasm Diseases 0.000 claims description 6
- 230000000527 lymphocytic effect Effects 0.000 claims description 6
- 230000035772 mutation Effects 0.000 claims description 6
- 208000025113 myeloid leukemia Diseases 0.000 claims description 6
- 208000017805 post-transplant lymphoproliferative disease Diseases 0.000 claims description 6
- 201000011549 stomach cancer Diseases 0.000 claims description 6
- 208000002008 AIDS-Related Lymphoma Diseases 0.000 claims description 5
- 201000009030 Carcinoma Diseases 0.000 claims description 5
- 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims description 5
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 5
- 208000017604 Hodgkin disease Diseases 0.000 claims description 5
- 208000021519 Hodgkin lymphoma Diseases 0.000 claims description 5
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims description 5
- 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims description 5
- 206010025312 Lymphoma AIDS related Diseases 0.000 claims description 5
- 229920001481 poly(stearyl methacrylate) Polymers 0.000 claims description 5
- 102100040842 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3 Human genes 0.000 claims description 4
- 102100038080 B-cell receptor CD22 Human genes 0.000 claims description 4
- 102100038078 CD276 antigen Human genes 0.000 claims description 4
- 102100025475 Carcinoembryonic antigen-related cell adhesion molecule 5 Human genes 0.000 claims description 4
- 102100038083 Endosialin Human genes 0.000 claims description 4
- 101000893701 Homo sapiens 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3 Proteins 0.000 claims description 4
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims description 4
- 101000914324 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 5 Proteins 0.000 claims description 4
- 101000884275 Homo sapiens Endosialin Proteins 0.000 claims description 4
- 101001063456 Homo sapiens Leucine-rich repeat-containing G-protein coupled receptor 5 Proteins 0.000 claims description 4
- 101001051490 Homo sapiens Neural cell adhesion molecule L1 Proteins 0.000 claims description 4
- 101001117317 Homo sapiens Programmed cell death 1 ligand 1 Proteins 0.000 claims description 4
- 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 claims description 4
- 101000610551 Homo sapiens Prominin-1 Proteins 0.000 claims description 4
- 101000633784 Homo sapiens SLAM family member 7 Proteins 0.000 claims description 4
- 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 claims description 4
- 102100031036 Leucine-rich repeat-containing G-protein coupled receptor 5 Human genes 0.000 claims description 4
- 102000018697 Membrane Proteins Human genes 0.000 claims description 4
- 108010052285 Membrane Proteins Proteins 0.000 claims description 4
- 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 claims description 4
- 102100040120 Prominin-1 Human genes 0.000 claims description 4
- 102100029198 SLAM family member 7 Human genes 0.000 claims description 4
- 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 claims description 4
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 claims description 4
- 235000003704 aspartic acid Nutrition 0.000 claims description 4
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 4
- 210000004899 c-terminal region Anatomy 0.000 claims description 4
- 201000010099 disease Diseases 0.000 claims description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 4
- 239000000833 heterodimer Substances 0.000 claims description 4
- 230000028993 immune response Effects 0.000 claims description 4
- 238000001727 in vivo Methods 0.000 claims description 4
- 108020004707 nucleic acids Proteins 0.000 claims description 4
- 102000039446 nucleic acids Human genes 0.000 claims description 4
- 150000007523 nucleic acids Chemical class 0.000 claims description 4
- OZDAOHVKBFBBMZ-UHFFFAOYSA-N 2-aminopentanedioic acid;hydrate Chemical compound O.OC(=O)C(N)CCC(O)=O OZDAOHVKBFBBMZ-UHFFFAOYSA-N 0.000 claims description 3
- 208000003950 B-cell lymphoma Diseases 0.000 claims description 3
- 208000028564 B-cell non-Hodgkin lymphoma Diseases 0.000 claims description 3
- 206010004146 Basal cell carcinoma Diseases 0.000 claims description 3
- 206010005003 Bladder cancer Diseases 0.000 claims description 3
- 206010005949 Bone cancer Diseases 0.000 claims description 3
- 208000018084 Bone neoplasm Diseases 0.000 claims description 3
- 206010006187 Breast cancer Diseases 0.000 claims description 3
- 208000026310 Breast neoplasm Diseases 0.000 claims description 3
- 101710188619 C-type lectin domain family 12 member A Proteins 0.000 claims description 3
- 206010008342 Cervix carcinoma Diseases 0.000 claims description 3
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 3
- 208000006332 Choriocarcinoma Diseases 0.000 claims description 3
- 206010009944 Colon cancer Diseases 0.000 claims description 3
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims description 3
- 208000002699 Digestive System Neoplasms Diseases 0.000 claims description 3
- 206010014733 Endometrial cancer Diseases 0.000 claims description 3
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims description 3
- 206010017993 Gastrointestinal neoplasms Diseases 0.000 claims description 3
- 101000984929 Homo sapiens Butyrophilin subfamily 1 member A1 Proteins 0.000 claims description 3
- 101000984925 Homo sapiens Butyrophilin subfamily 2 member A2 Proteins 0.000 claims description 3
- 101000934738 Homo sapiens Butyrophilin-like protein 2 Proteins 0.000 claims description 3
- 101000934743 Homo sapiens Butyrophilin-like protein 9 Proteins 0.000 claims description 3
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims description 3
- 101000984932 Homo sapiens Putative butyrophilin subfamily 2 member A3 Proteins 0.000 claims description 3
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 3
- 206010023825 Laryngeal cancer Diseases 0.000 claims description 3
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 3
- 208000006395 Meigs Syndrome Diseases 0.000 claims description 3
- 208000003445 Mouth Neoplasms Diseases 0.000 claims description 3
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims description 3
- 206010029260 Neuroblastoma Diseases 0.000 claims description 3
- 206010030113 Oedema Diseases 0.000 claims description 3
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims description 3
- 206010033128 Ovarian cancer Diseases 0.000 claims description 3
- 206010061535 Ovarian neoplasm Diseases 0.000 claims description 3
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 3
- 206010035226 Plasma cell myeloma Diseases 0.000 claims description 3
- 102100027141 Putative butyrophilin subfamily 2 member A3 Human genes 0.000 claims description 3
- 208000015634 Rectal Neoplasms Diseases 0.000 claims description 3
- 201000000582 Retinoblastoma Diseases 0.000 claims description 3
- 208000004337 Salivary Gland Neoplasms Diseases 0.000 claims description 3
- 206010061934 Salivary gland cancer Diseases 0.000 claims description 3
- 208000000453 Skin Neoplasms Diseases 0.000 claims description 3
- 206010041067 Small cell lung cancer Diseases 0.000 claims description 3
- 208000024313 Testicular Neoplasms Diseases 0.000 claims description 3
- 206010057644 Testis cancer Diseases 0.000 claims description 3
- 208000024770 Thyroid neoplasm Diseases 0.000 claims description 3
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims description 3
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims description 3
- 208000002495 Uterine Neoplasms Diseases 0.000 claims description 3
- 208000004354 Vulvar Neoplasms Diseases 0.000 claims description 3
- 230000002159 abnormal effect Effects 0.000 claims description 3
- 210000002203 alpha-beta t lymphocyte Anatomy 0.000 claims description 3
- 230000000890 antigenic effect Effects 0.000 claims description 3
- 108010081355 beta 2-Microglobulin Proteins 0.000 claims description 3
- 201000009036 biliary tract cancer Diseases 0.000 claims description 3
- 208000020790 biliary tract neoplasm Diseases 0.000 claims description 3
- 210000003169 central nervous system Anatomy 0.000 claims description 3
- 201000007455 central nervous system cancer Diseases 0.000 claims description 3
- 201000010881 cervical cancer Diseases 0.000 claims description 3
- 201000010918 connective tissue cancer Diseases 0.000 claims description 3
- 201000004101 esophageal cancer Diseases 0.000 claims description 3
- 208000024519 eye neoplasm Diseases 0.000 claims description 3
- 208000005017 glioblastoma Diseases 0.000 claims description 3
- 235000013922 glutamic acid Nutrition 0.000 claims description 3
- 201000010536 head and neck cancer Diseases 0.000 claims description 3
- 208000014829 head and neck neoplasm Diseases 0.000 claims description 3
- 206010073071 hepatocellular carcinoma Diseases 0.000 claims description 3
- 231100000844 hepatocellular carcinoma Toxicity 0.000 claims description 3
- 208000020082 intraepithelial neoplasia Diseases 0.000 claims description 3
- 210000003734 kidney Anatomy 0.000 claims description 3
- 206010023841 laryngeal neoplasm Diseases 0.000 claims description 3
- 208000012987 lip and oral cavity carcinoma Diseases 0.000 claims description 3
- 208000000680 lipomatosis Diseases 0.000 claims description 3
- 201000005249 lung adenocarcinoma Diseases 0.000 claims description 3
- 201000005202 lung cancer Diseases 0.000 claims description 3
- 208000020816 lung neoplasm Diseases 0.000 claims description 3
- 201000005243 lung squamous cell carcinoma Diseases 0.000 claims description 3
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 3
- 201000001441 melanoma Diseases 0.000 claims description 3
- 201000000050 myeloid neoplasm Diseases 0.000 claims description 3
- 208000002154 non-small cell lung carcinoma Diseases 0.000 claims description 3
- 201000008106 ocular cancer Diseases 0.000 claims description 3
- 201000002528 pancreatic cancer Diseases 0.000 claims description 3
- 208000008443 pancreatic carcinoma Diseases 0.000 claims description 3
- 201000002628 peritoneum cancer Diseases 0.000 claims description 3
- 210000003800 pharynx Anatomy 0.000 claims description 3
- 206010038038 rectal cancer Diseases 0.000 claims description 3
- 201000001275 rectum cancer Diseases 0.000 claims description 3
- 201000009410 rhabdomyosarcoma Diseases 0.000 claims description 3
- 201000000849 skin cancer Diseases 0.000 claims description 3
- 208000000587 small cell lung carcinoma Diseases 0.000 claims description 3
- 206010041823 squamous cell carcinoma Diseases 0.000 claims description 3
- 230000004936 stimulating effect Effects 0.000 claims description 3
- 201000003120 testicular cancer Diseases 0.000 claims description 3
- 201000002510 thyroid cancer Diseases 0.000 claims description 3
- 108010055094 transporter associated with antigen processing (TAP) Proteins 0.000 claims description 3
- 208000029729 tumor suppressor gene on chromosome 11 Diseases 0.000 claims description 3
- 201000005112 urinary bladder cancer Diseases 0.000 claims description 3
- 230000002485 urinary effect Effects 0.000 claims description 3
- 206010046766 uterine cancer Diseases 0.000 claims description 3
- BGFTWECWAICPDG-UHFFFAOYSA-N 2-[bis(4-chlorophenyl)methyl]-4-n-[3-[bis(4-chlorophenyl)methyl]-4-(dimethylamino)phenyl]-1-n,1-n-dimethylbenzene-1,4-diamine Chemical compound C1=C(C(C=2C=CC(Cl)=CC=2)C=2C=CC(Cl)=CC=2)C(N(C)C)=CC=C1NC(C=1)=CC=C(N(C)C)C=1C(C=1C=CC(Cl)=CC=1)C1=CC=C(Cl)C=C1 BGFTWECWAICPDG-UHFFFAOYSA-N 0.000 claims description 2
- 102100031585 ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Human genes 0.000 claims description 2
- 101001005269 Arabidopsis thaliana Ceramide synthase 1 LOH3 Proteins 0.000 claims description 2
- 101001005312 Arabidopsis thaliana Ceramide synthase LOH1 Proteins 0.000 claims description 2
- 101100279855 Arabidopsis thaliana EPFL5 gene Proteins 0.000 claims description 2
- CKLJMWTZIZZHCS-UHFFFAOYSA-N Aspartic acid Chemical compound OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims description 2
- 108010008014 B-Cell Maturation Antigen Proteins 0.000 claims description 2
- 102000006942 B-Cell Maturation Antigen Human genes 0.000 claims description 2
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims description 2
- 102100027140 Butyrophilin subfamily 1 member A1 Human genes 0.000 claims description 2
- 102100027156 Butyrophilin subfamily 2 member A2 Human genes 0.000 claims description 2
- 102100025375 Butyrophilin-like protein 10 Human genes 0.000 claims description 2
- 102100025429 Butyrophilin-like protein 2 Human genes 0.000 claims description 2
- 102100025374 Butyrophilin-like protein 9 Human genes 0.000 claims description 2
- 101710185679 CD276 antigen Proteins 0.000 claims description 2
- 102100032912 CD44 antigen Human genes 0.000 claims description 2
- 102100025221 CD70 antigen Human genes 0.000 claims description 2
- 101150031358 COLEC10 gene Proteins 0.000 claims description 2
- 102000000905 Cadherin Human genes 0.000 claims description 2
- 108050007957 Cadherin Proteins 0.000 claims description 2
- 102100024153 Cadherin-15 Human genes 0.000 claims description 2
- 102100024152 Cadherin-17 Human genes 0.000 claims description 2
- 102100024423 Carbonic anhydrase 9 Human genes 0.000 claims description 2
- 102100036466 Delta-like protein 3 Human genes 0.000 claims description 2
- 101150084967 EPCAM gene Proteins 0.000 claims description 2
- 101150076616 EPHA2 gene Proteins 0.000 claims description 2
- 102100030340 Ephrin type-A receptor 2 Human genes 0.000 claims description 2
- 102100031507 Fc receptor-like protein 5 Human genes 0.000 claims description 2
- 102100035139 Folate receptor alpha Human genes 0.000 claims description 2
- 102100021197 G-protein coupled receptor family C group 5 member D Human genes 0.000 claims description 2
- 102100032530 Glypican-3 Human genes 0.000 claims description 2
- 101000777636 Homo sapiens ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 Proteins 0.000 claims description 2
- 101000834898 Homo sapiens Alpha-synuclein Proteins 0.000 claims description 2
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims description 2
- 101000934745 Homo sapiens Butyrophilin-like protein 10 Proteins 0.000 claims description 2
- 101000912622 Homo sapiens C-type lectin domain family 12 member A Proteins 0.000 claims description 2
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 2
- 101000934356 Homo sapiens CD70 antigen Proteins 0.000 claims description 2
- 101100496086 Homo sapiens CLEC12A gene Proteins 0.000 claims description 2
- 101000762242 Homo sapiens Cadherin-15 Proteins 0.000 claims description 2
- 101000762247 Homo sapiens Cadherin-17 Proteins 0.000 claims description 2
- 101000714553 Homo sapiens Cadherin-3 Proteins 0.000 claims description 2
- 101000910338 Homo sapiens Carbonic anhydrase 9 Proteins 0.000 claims description 2
- 101000914321 Homo sapiens Carcinoembryonic antigen-related cell adhesion molecule 7 Proteins 0.000 claims description 2
- 101000928513 Homo sapiens Delta-like protein 3 Proteins 0.000 claims description 2
- 101000846908 Homo sapiens Fc receptor-like protein 5 Proteins 0.000 claims description 2
- 101001023230 Homo sapiens Folate receptor alpha Proteins 0.000 claims description 2
- 101001040713 Homo sapiens G-protein coupled receptor family C group 5 member D Proteins 0.000 claims description 2
- 101001014668 Homo sapiens Glypican-3 Proteins 0.000 claims description 2
- 101100232357 Homo sapiens IL13RA1 gene Proteins 0.000 claims description 2
- 101100232360 Homo sapiens IL13RA2 gene Proteins 0.000 claims description 2
- 101001103039 Homo sapiens Inactive tyrosine-protein kinase transmembrane receptor ROR1 Proteins 0.000 claims description 2
- 101000960952 Homo sapiens Interleukin-1 receptor accessory protein Proteins 0.000 claims description 2
- 101000998120 Homo sapiens Interleukin-3 receptor subunit alpha Proteins 0.000 claims description 2
- 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 claims description 2
- 101000576802 Homo sapiens Mesothelin Proteins 0.000 claims description 2
- 101000628547 Homo sapiens Metalloreductase STEAP1 Proteins 0.000 claims description 2
- 101001133056 Homo sapiens Mucin-1 Proteins 0.000 claims description 2
- 101000623901 Homo sapiens Mucin-16 Proteins 0.000 claims description 2
- 101000623904 Homo sapiens Mucin-17 Proteins 0.000 claims description 2
- 101001109501 Homo sapiens NKG2-D type II integral membrane protein Proteins 0.000 claims description 2
- 101001103036 Homo sapiens Nuclear receptor ROR-alpha Proteins 0.000 claims description 2
- 101000617725 Homo sapiens Pregnancy-specific beta-1-glycoprotein 2 Proteins 0.000 claims description 2
- 101001136592 Homo sapiens Prostate stem cell antigen Proteins 0.000 claims description 2
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims description 2
- 101000932478 Homo sapiens Receptor-type tyrosine-protein kinase FLT3 Proteins 0.000 claims description 2
- 101000829127 Homo sapiens Somatostatin receptor type 2 Proteins 0.000 claims description 2
- 101000652359 Homo sapiens Spermatogenesis-associated protein 2 Proteins 0.000 claims description 2
- 101000831007 Homo sapiens T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 claims description 2
- 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 claims description 2
- 101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 claims description 2
- 101000801433 Homo sapiens Trophoblast glycoprotein Proteins 0.000 claims description 2
- 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 claims description 2
- 102100039615 Inactive tyrosine-protein kinase transmembrane receptor ROR1 Human genes 0.000 claims description 2
- 102100039880 Interleukin-1 receptor accessory protein Human genes 0.000 claims description 2
- 102100020791 Interleukin-13 receptor subunit alpha-1 Human genes 0.000 claims description 2
- 102100033493 Interleukin-3 receptor subunit alpha Human genes 0.000 claims description 2
- 102000017578 LAG3 Human genes 0.000 claims description 2
- 101150030213 Lag3 gene Proteins 0.000 claims description 2
- 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 claims description 2
- 108090000015 Mesothelin Proteins 0.000 claims description 2
- 102000003735 Mesothelin Human genes 0.000 claims description 2
- 102100025096 Mesothelin Human genes 0.000 claims description 2
- 102100026712 Metalloreductase STEAP1 Human genes 0.000 claims description 2
- 102100034256 Mucin-1 Human genes 0.000 claims description 2
- 102100023123 Mucin-16 Human genes 0.000 claims description 2
- 102100023125 Mucin-17 Human genes 0.000 claims description 2
- 102100022680 NKG2-D type II integral membrane protein Human genes 0.000 claims description 2
- 108010012255 Neural Cell Adhesion Molecule L1 Proteins 0.000 claims description 2
- 108060006580 PRAME Proteins 0.000 claims description 2
- 102000036673 PRAME Human genes 0.000 claims description 2
- 101710089372 Programmed cell death protein 1 Proteins 0.000 claims description 2
- 102100036735 Prostate stem cell antigen Human genes 0.000 claims description 2
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims description 2
- 102100020718 Receptor-type tyrosine-protein kinase FLT3 Human genes 0.000 claims description 2
- 102100023802 Somatostatin receptor type 2 Human genes 0.000 claims description 2
- 101000668858 Spinacia oleracea 30S ribosomal protein S1, chloroplastic Proteins 0.000 claims description 2
- 101000898746 Streptomyces clavuligerus Clavaminate synthase 1 Proteins 0.000 claims description 2
- 102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 claims description 2
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims description 2
- 102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 claims description 2
- 102100033579 Trophoblast glycoprotein Human genes 0.000 claims description 2
- 108010053099 Vascular Endothelial Growth Factor Receptor-2 Proteins 0.000 claims description 2
- 125000000151 cysteine group Chemical group N[C@@H](CS)C(=O)* 0.000 claims description 2
- 229940127276 delta-like ligand 3 Drugs 0.000 claims description 2
- 230000009881 electrostatic interaction Effects 0.000 claims description 2
- 108010087914 epidermal growth factor receptor VIII Proteins 0.000 claims description 2
- 102000052116 epidermal growth factor receptor activity proteins Human genes 0.000 claims description 2
- 108700015053 epidermal growth factor receptor activity proteins Proteins 0.000 claims description 2
- 239000000710 homodimer Substances 0.000 claims description 2
- YOHYSYJDKVYCJI-UHFFFAOYSA-N n-[3-[[6-[3-(trifluoromethyl)anilino]pyrimidin-4-yl]amino]phenyl]cyclopropanecarboxamide Chemical compound FC(F)(F)C1=CC=CC(NC=2N=CN=C(NC=3C=C(NC(=O)C4CC4)C=CC=3)C=2)=C1 YOHYSYJDKVYCJI-UHFFFAOYSA-N 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims description 2
- 201000007048 respiratory system cancer Diseases 0.000 claims description 2
- 101150047061 tag-72 gene Proteins 0.000 claims description 2
- 102100027314 Beta-2-microglobulin Human genes 0.000 claims 1
- 210000004204 blood vessel Anatomy 0.000 claims 1
- 238000000034 method Methods 0.000 description 32
- 210000000225 synapse Anatomy 0.000 description 6
- 230000001105 regulatory effect Effects 0.000 description 3
- 108020004414 DNA Proteins 0.000 description 2
- 206010047741 Vulval cancer Diseases 0.000 description 2
- 102000015736 beta 2-Microglobulin Human genes 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000001939 inductive effect Effects 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 230000010287 polarization Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 201000005102 vulva cancer Diseases 0.000 description 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 108010014223 Armadillo Domain Proteins Proteins 0.000 description 1
- 102000016904 Armadillo Domain Proteins Human genes 0.000 description 1
- 208000023275 Autoimmune disease Diseases 0.000 description 1
- 241000251730 Chondrichthyes Species 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 108010025905 Cystine-Knot Miniproteins Proteins 0.000 description 1
- 241000289632 Dasypodidae Species 0.000 description 1
- 108700022150 Designed Ankyrin Repeat Proteins Proteins 0.000 description 1
- 101710088083 Glomulin Proteins 0.000 description 1
- 102100033808 Glycoprotein hormone alpha-2 Human genes 0.000 description 1
- 101100382035 Homo sapiens BTN3A3 gene Proteins 0.000 description 1
- 101100437929 Homo sapiens BTNL10 gene Proteins 0.000 description 1
- 101001069261 Homo sapiens Glycoprotein hormone alpha-2 Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 102100023832 Prolyl endopeptidase FAP Human genes 0.000 description 1
- 108010003723 Single-Domain Antibodies Proteins 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- 210000004696 endometrium Anatomy 0.000 description 1
- 102000053656 human BTN1A1 Human genes 0.000 description 1
- 102000053655 human BTN2A1 Human genes 0.000 description 1
- 102000053582 human BTN2A2 Human genes 0.000 description 1
- 102000052434 human BTN3A1 Human genes 0.000 description 1
- 102000051770 human BTN3A2 Human genes 0.000 description 1
- 102000045264 human BTNL2 Human genes 0.000 description 1
- 102000048092 human BTNL8 Human genes 0.000 description 1
- 102000051261 human BTNL9 Human genes 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 210000002500 microbody Anatomy 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 239000013598 vector Substances 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063105744P | 2020-10-26 | 2020-10-26 | |
| US63/105,744 | 2020-10-26 | ||
| PCT/US2021/027294 WO2022093310A1 (en) | 2020-10-26 | 2021-04-14 | Homodimeric and heterodimeric proteins comprising butyrophilin |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023546725A JP2023546725A (ja) | 2023-11-07 |
| JP2023546725A5 JP2023546725A5 (https=) | 2024-04-24 |
| JPWO2022093310A5 true JPWO2022093310A5 (https=) | 2024-04-24 |
Family
ID=81384237
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023525078A Pending JP2023546725A (ja) | 2020-10-26 | 2021-04-14 | ブチロフィリンを含むホモ二量体及びヘテロ二量体タンパク質 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230416333A1 (https=) |
| EP (1) | EP4232065A4 (https=) |
| JP (1) | JP2023546725A (https=) |
| CN (1) | CN116801897A (https=) |
| AU (1) | AU2021370788A1 (https=) |
| CA (1) | CA3196533A1 (https=) |
| WO (1) | WO2022093310A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2024511992A (ja) * | 2021-03-16 | 2024-03-18 | シャタック ラボ，インコーポレイテッド | ガンマデルタｔ細胞刺激 |
| US20250179144A1 (en) * | 2021-12-09 | 2025-06-05 | The University Of Melbourne | Modified Butyrophilin and Butyrophilin Complexes |
| WO2024006907A2 (en) * | 2022-06-29 | 2024-01-04 | Shattuck Labs, Inc. | B7h3-targeted gamma delta t cell modulation |
| WO2024006889A2 (en) * | 2022-06-29 | 2024-01-04 | Shattuck Labs, Inc. | Cd20-targeted gamma delta t cell modulation |
| CN118388647A (zh) * | 2022-06-30 | 2024-07-26 | 深圳市乐土生物医药有限公司 | 一种分离的Claudin18.2抗体及其应用 |
| WO2024123812A1 (en) | 2022-12-05 | 2024-06-13 | Shattuck Labs, Inc. | Fusion proteins for the treatment of cardiometabolic diseases |
| CN121752279A (zh) * | 2023-06-30 | 2026-03-27 | 科瑞特医药公司 | 工程化嵌合融合蛋白组合物及其使用方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2766200C1 (ru) * | 2015-10-01 | 2022-02-09 | Хит Байолоджикс, Инк. | Композиции и способы для соединения внеклеточных доменов типа i и типа ii в качестве гетерологичных химерных белков |
| WO2020047329A1 (en) * | 2018-08-29 | 2020-03-05 | Shattuck Labs, Inc. | Chimeric proteins comprising extracellular domains and uses thereof |
| US11098093B2 (en) * | 2019-01-07 | 2021-08-24 | Shattuck Labs, Inc. | Heterodimeric proteins for modulating gamma delta T cells |
| WO2020146393A1 (en) * | 2019-01-07 | 2020-07-16 | Shattuck Labs. Inc. | Heterodimeric proteins for modulating gamma delta t cells |
-
2021
- 2021-04-14 CA CA3196533A patent/CA3196533A1/en active Pending
- 2021-04-14 US US18/033,403 patent/US20230416333A1/en active Pending
- 2021-04-14 AU AU2021370788A patent/AU2021370788A1/en not_active Abandoned
- 2021-04-14 CN CN202180087304.4A patent/CN116801897A/zh active Pending
- 2021-04-14 JP JP2023525078A patent/JP2023546725A/ja active Pending
- 2021-04-14 WO PCT/US2021/027294 patent/WO2022093310A1/en not_active Ceased
- 2021-04-14 EP EP21887084.8A patent/EP4232065A4/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020530299A5 (https=) | ||
| JP2024059628A (ja) | Ｃｄ１９指向性キメラ抗原受容体および免疫療法におけるその使用 | |
| WO2021147928A1 (zh) | 包含嵌合抗原受体的免疫细胞及其用途 | |
| ES2737690T3 (es) | Variantes de APRIL | |
| JP2023139070A5 (https=) | ||
| JP2022058385A5 (https=) | ||
| US20230028399A1 (en) | Bcma-directed cellular immunotherapy compositions and methods | |
| JP2020527939A (ja) | タンパク質性ヘテロ二量体及びその用途 | |
| JP2019523630A5 (https=) | ||
| JP2018046811A (ja) | 異常細胞を標的とする多重特異性結合分子 | |
| CN107636015A (zh) | 包含结合蛋白和对IL‑15Rα具有降低亲和力的白介素‑15多肽的融合蛋白及其治疗用途 | |
| Murad et al. | Advances in the use of natural receptor-or ligand-based chimeric antigen receptors (CARs) in haematologic malignancies | |
| CN115698088A (zh) | 免疫细胞衔接器多特异性结合蛋白及其制备和应用 | |
| JP2024519335A (ja) | がん免疫療法のための投薬レジメン | |
| WO2023006082A1 (zh) | 抗原靶向、抗cd16a和免疫效应细胞激活三功能融合蛋白及其应用 | |
| WO2022262678A1 (zh) | 一种多特异性抗原结合蛋白及其应用 | |
| JPWO2019191120A5 (https=) | ||
| AU2021282053A1 (en) | Fc-CD80 fusion protein and conjugate thereof, and use thereof | |
| WO2024078479A1 (zh) | 一种异源二聚体融合蛋白及其应用 | |
| JPWO2022093310A5 (https=) | ||
| CN117004604A (zh) | 一种ciita基因被敲除的工程化免疫细胞及其用途 | |
| CN117187185A (zh) | 一种工程化免疫细胞及其用途 | |
| JP7819944B2 (ja) | Ｉｌ－２バリアント | |
| WO2024193705A1 (en) | Tnf superfamily member immunocytokine and uses thereof | |
| US20250326813A1 (en) | Engineered interleukin-2 receptor beta reduced-binding agonist |